Founder
Apricot Therapeutics
Apricot Therapeutics utilizes high-plex image-based profiling to analyze the spatial drug responses of individual cancer cells, enabling precise treatment decisions tailored to each patient's unique tumor composition. Their platform provides detailed cellular drug response data, facilitating the prioritization of drug candidates for clinicians, researchers, and drug developers in the field of functional precision medicine.
- Biotechnology
- Healthcare Technology
Updated 7 months ago
Funding
Raised to date
$10KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Apricot Therapeutics utilizes high-plex image-based profiling to analyze the spatial drug responses of individual cancer cells, enabling precise treatment decisions tailored to each patient's unique tumor composition. Their platform provides detailed cellular drug response data, facilitating the prioritization of drug candidates for clinicians, researchers, and drug developers in the field of functional precision medicine.